Investor Presentaiton
Global market leader for aseptic process solutions
Who is SKAN ?
A global market leader in high-end,
mission-critical isolator solutions for
aseptic and aseptic-toxic production
processes across (bio-)pharma
Pioneer in the isolator technology
with 50+ years of experience in
cleanroom equipment
Trusted, long-term partner to almost
all major blue-chip (bio-)pharma
companies
Diversified customer base with more
than 1,000 total active customers
Global footprint across Europe,
North America and Asia
SKAN aseptic process offering
Equipment & Solutions
(75%)
Customized and standard
isolator solutions
Automated aseptic filling
stations, e.g. for cell &
gene therapy
Process solution from
design & engineering to
process qualification
SKAN key figures
Q-0
-0-0-0-0-0
CHF 277.0m
+18.2%
CHF 40.2m
14.5%
Net sales
2022
Net sales growth
2021-22
EBITDA
2022
EBITDA margin
2022
November 2023
SKAN Group AG Investor Presentation
(1) Management estimation of the market share within the premium high-value market.
Services & Consumables
(25%)
ā Lifecycle management
services
Consumables: transfer
connectors, closed vials,
etc.
50-60%
Market share(1)
CHF 360.1m
Order backlog
2022
6
SKANView entire presentation